인슐린 전달 기기 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 연평균 8.2%의 연평균 성장률(CAGR)로 263억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 당뇨병 인구 증가, 당뇨병 치료에 대한 의료비 증가, 연속 혈당 모니터링 시스템의 부상, 자동 인슐린 전달 기기의 이점에 대한 환자 인식 증가, 헬스케어에 대한 관심 증가에 기인합니다. 예측 기간 동안 주요 동향으로는 인슐린 전달 기기의 기술 발전, 디지털 기술과 인슐린 전달 기기의 통합, 인공 췌장 시스템의 개발, 인슐린 투여 기술의 발전, 바이오닉 기술의 발전 등을 들 수 있습니다.
당뇨병 유병률의 증가는 향후 몇 년 동안 인슐린 전달 기기 시장의 성장을 촉진할 것으로 예상됩니다. 당뇨병은 췌장의 인슐린 분비가 불충분하거나 신체가 인슐린을 효과적으로 사용하지 못하여 혈당치가 상승하는 만성질환입니다. 당뇨병 환자의 증가는 앉아서 생활하는 생활습관, 식생활의 변화, 전 세계 비만율 증가 등의 요인에 기인하는 바가 큽니다. 인슐린 전달 기기는 당뇨병을 관리하는 데 필수적인 요소입니다. 인슐린을 조절하고 편리한 방법으로 투여함으로써 혈당을 효과적으로 조절하고 합병증을 예방하며 전반적인 건강을 증진시킬 수 있기 때문입니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 2022년 12월 기준 미국 내 20세 미만 제2형 당뇨병 환자 수는 2060년까지 700% 가까이 증가하여 22만 명에 달할 것으로 예상하고 있습니다. 또한, 같은 기간 동안 젊은층의 제1형 당뇨병 진단은 65%까지 증가할 수 있습니다. 이러한 당뇨병 유병률의 증가는 인슐린 전달 기기 시장 확대에 박차를 가하고 있습니다.
인슐린 전달 기기 시장의 주요 기업들은 지속적 또는 맞춤형 인슐린 전달을 제공하는 인슐린 펌프와 같은 혁신적인 제품 개발에 주력하고 있습니다. 인슐린 펌프는 피하에 삽입된 카테터를 통해 인슐린을 지속적으로 또는 필요에 따라 전달할 수 있는 프로그래밍이 가능한 의료기기입니다. 예를 들어, 2023년 5월 미국 의료 기술 기업 베타 바이오닉스(Beta Bionics)는 미국 식품의약국으로부터 iLet ACE Pump와 iLet Dosing Decision Software에 대한 승인을 받았습니다. 6세 이상의 1형 당뇨병 환자를 위해 설계된 iLet Bionic Pancreas 시스템은 호환 가능한 FDA 승인 통합 지속형 혈당 모니터(iCGM)와 두 가지 기기를 통합합니다. 이 시스템은 적응형 폐쇄 루프 알고리즘에 의해 구동되는 자동 인슐린 투여(AID) 시스템을 통해 작동하며, 설정에 필요한 것은 사용자의 체중뿐이며 추가적인 인슐린 투여 파라미터는 필요하지 않습니다. 기존 펌프 요법과 달리 이 시스템은 수동으로 설정을 조정할 필요가 없기 때문에 시작과 관리가 용이합니다. 또한, iLet 기기는 식사 알림 기능을 도입하여 식사를 소, 중, 대 식사로 분류하여 식사 시 인슐린 투여를 간소화합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 인슐린 전달 기기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 인슐린 전달 기기 시장 : 성장률 분석
- 세계의 인슐린 전달 기기 시장 실적 : 규모와 성장, 2019-2024
- 세계의 인슐린 전달 기기 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 인슐린 전달 기기 전체 시장(TAM)
제6장 시장 세분화
- 세계의 인슐린 전달 기기 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 인슐린 주사기
- 인슐린 제트 인젝터
- 펜니들
- 재사용 가능한 인슐린 펜
- 일회용 인슐린 펜
- 인슐린 펌프
- 외부 펌프 또는 테더 펌프
- 패치 펌프
- 세계의 인슐린 전달 기기 시장 : 질환 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 유형 1
- 유형 2
- 세계의 인슐린 전달 기기 시장 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 판매
- 당뇨병 클리닉 또는 센터
- 세계의 인슐린 전달 기기 시장 인슐린 주사기 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 표준 인슐린 주사기
- 고정 또는 조절 가능한 바늘 길이를 갖춘 인슐린 주사기
- 세계의 인슐린 전달 기기 시장 인슐린 제트 인젝터 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 무바늘 인슐린 제트 주사기
- 고압 인슐린 제트 인젝터
- 세계의 인슐린 전달 기기 시장 펜니들 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 쇼트 펜니들
- 롱 펜니들
- 세계의 인슐린 전달 기기 시장 재사용 가능한 인슐린 펜 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 교환 가능한 카트리지를 갖춘 재사용 가능한 펜
- 재충전 가능한 인슐린 펜
- 세계의 인슐린 전달 기기 시장 일회용 인슐린 펜 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 일회용 인슐린 펜
- 일회용 프리필드 인슐린 펜
- 세계의 인슐린 전달 기기 시장 인슐린 펌프 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 기존 인슐린 펌프
- 스마트 인슐린 펌프
- 세계의 인슐린 전달 기기 시장 외부 펌프 또는 테더 펌프 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 기존 외부 인슐린 펌프
- 무선 테더 펌프
- 세계의 인슐린 전달 기기 시장 패치 펌프 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 패치형 인슐린 펌프
- 통합 패치 펌프
제7장 지역별·국가별 분석
- 세계의 인슐린 전달 기기 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 인슐린 전달 기기 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 인슐린 전달 기기 시장 : 경쟁 구도
- 인슐린 전달 기기 시장 : 기업 개요
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
- Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Novo Nordisk A/S
- Becton, Dickinson and Company
- EOFlow Co. Ltd.
- Insulet Corporation
- Tandem Diabetes Care Inc.
- Ypsomed Holding AG
- Xeris Pharmaceuticals Inc.
- Beta Bionics Inc.
- Zealand Pharma AS
- Bigfoot Biomedical Inc.
- Emperra GmbH
- Animas Corporation
- Debiotech SA
- CeQur Corporation
- Aerami Therapeutics Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 인슐린 전달 기기 시장 2029 : 새로운 기회를 제공하는 국가
- 인슐린 전달 기기 시장 2029 : 새로운 기회를 제공하는 부문
- 인슐린 전달 기기 시장 2029 : 성장 전략
제36장 부록
ksm
Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.
The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.
The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The insulin delivery devices market size has grown strongly in recent years. It will grow from $17.71 billion in 2024 to $19.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, increasing prevalence of obesity, growing aging population, increasing adoption of insulin pumps.
The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $26.3 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing prevalence of diabetic population, increasing healthcare expenditure on diabetes care, rise of continuous glucose monitoring systems, growing awareness among patients about benefits of automated insulin delivery devices, rising focus on healthcare. Major trends in the forecast period include technological advancements in insulin delivery devices, integration of digital technology with insulin delivery devices, development of artificial pancreas systems, advancements in insulin administration technology, bionic technology advancements.
The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the Centers for Disease Control and Prevention, a U.S.-based government agency, as of December 2022, the number of young people under 20 with type 2 diabetes in the United States could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Additionally, diagnoses of type 1 diabetes among young people could rise by as much as 65% over the same period. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.
Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.
In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.
Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices
North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Insulin Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens; Insulin Pumps; External Or Tethered Pumps; Patch Pumps
- 2) By Disease Indication: Type 1; Type 2
- 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
- Subsegments:
- 1) By Insulin Syringes: Standard Insulin Syringes; Insulin Syringes With Fixed Or Adjustable Needle Length
- 2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors; High-Pressure Insulin Jet Injectors
- 3) By Pen Needles: Short Pen Needles; Long Pen Needles
- 4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges; Refillable Insulin Pens
- 5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens; Pre-Filled Disposable Insulin Pens
- 6) By Insulin Pumps: Traditional Insulin Pumps; Smart Insulin Pumps
- 7) By External Or Tethered Pumps: Traditional External Insulin Pumps; Wireless Tethered Pumps
- 8) By Patch Pumps: Patch Insulin Pumps; Integrated Patch Pumps
- Companies Mentioned: Sanofi SA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Eli Lilly and Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Insulin Delivery Devices Market Characteristics
3. Insulin Delivery Devices Market Trends And Strategies
4. Insulin Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Insulin Delivery Devices Growth Analysis And Strategic Analysis Framework
- 5.1. Global Insulin Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Insulin Delivery Devices Market Growth Rate Analysis
- 5.4. Global Insulin Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Insulin Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Insulin Delivery Devices Total Addressable Market (TAM)
6. Insulin Delivery Devices Market Segmentation
- 6.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Insulin Syringes
- Insulin Jet Injectors
- Pen Needles
- Reusable Insulin Pens
- Disposable Insulin Pens
- Insulin Pumps
- External Or Tethered Pumps
- Patch Pumps
- 6.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Type 1
- Type 2
- 6.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Diabetes Clinics Or Centres
- 6.4. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Standard Insulin Syringes
- Insulin Syringes With Fixed Or Adjustable Needle Length
- 6.5. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Needle-Free Insulin Jet Injectors
- High-Pressure Insulin Jet Injectors
- 6.6. Global Insulin Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Short Pen Needles
- Long Pen Needles
- 6.7. Global Insulin Delivery Devices Market, Sub-Segmentation Of Reusable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Reusable Pens With Replaceable Cartridges
- Refillable Insulin Pens
- 6.8. Global Insulin Delivery Devices Market, Sub-Segmentation Of Disposable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Use Disposable Insulin Pens
- Pre-Filled Disposable Insulin Pens
- 6.9. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Traditional Insulin Pumps
- Smart Insulin Pumps
- 6.10. Global Insulin Delivery Devices Market, Sub-Segmentation Of External Or Tethered Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Traditional External Insulin Pumps
- Wireless Tethered Pumps
- 6.11. Global Insulin Delivery Devices Market, Sub-Segmentation Of Patch Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Patch Insulin Pumps
- Integrated Patch Pumps
7. Insulin Delivery Devices Market Regional And Country Analysis
- 7.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Insulin Delivery Devices Market
- 8.1. Asia-Pacific Insulin Delivery Devices Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Insulin Delivery Devices Market
- 9.1. China Insulin Delivery Devices Market Overview
- 9.2. China Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Insulin Delivery Devices Market
- 10.1. India Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Insulin Delivery Devices Market
- 11.1. Japan Insulin Delivery Devices Market Overview
- 11.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Insulin Delivery Devices Market
- 12.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Insulin Delivery Devices Market
- 13.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Insulin Delivery Devices Market
- 14.1. South Korea Insulin Delivery Devices Market Overview
- 14.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Insulin Delivery Devices Market
- 15.1. Western Europe Insulin Delivery Devices Market Overview
- 15.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Insulin Delivery Devices Market
- 16.1. UK Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Insulin Delivery Devices Market
- 17.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Insulin Delivery Devices Market
- 18.1. France Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Insulin Delivery Devices Market
- 19.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Insulin Delivery Devices Market
- 20.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Insulin Delivery Devices Market
- 21.1. Eastern Europe Insulin Delivery Devices Market Overview
- 21.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Insulin Delivery Devices Market
- 22.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Insulin Delivery Devices Market
- 23.1. North America Insulin Delivery Devices Market Overview
- 23.2. North America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Insulin Delivery Devices Market
- 24.1. USA Insulin Delivery Devices Market Overview
- 24.2. USA Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Insulin Delivery Devices Market
- 25.1. Canada Insulin Delivery Devices Market Overview
- 25.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Insulin Delivery Devices Market
- 26.1. South America Insulin Delivery Devices Market Overview
- 26.2. South America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Insulin Delivery Devices Market
- 27.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Insulin Delivery Devices Market
- 28.1. Middle East Insulin Delivery Devices Market Overview
- 28.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Insulin Delivery Devices Market
- 29.1. Africa Insulin Delivery Devices Market Overview
- 29.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Insulin Delivery Devices Market Competitive Landscape And Company Profiles
- 30.1. Insulin Delivery Devices Market Competitive Landscape
- 30.2. Insulin Delivery Devices Market Company Profiles
- 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
31. Insulin Delivery Devices Market Other Major And Innovative Companies
- 31.1. Novo Nordisk A/S
- 31.2. Becton, Dickinson and Company
- 31.3. EOFlow Co. Ltd.
- 31.4. Insulet Corporation
- 31.5. Tandem Diabetes Care Inc.
- 31.6. Ypsomed Holding AG
- 31.7. Xeris Pharmaceuticals Inc.
- 31.8. Beta Bionics Inc.
- 31.9. Zealand Pharma AS
- 31.10. Bigfoot Biomedical Inc.
- 31.11. Emperra GmbH
- 31.12. Animas Corporation
- 31.13. Debiotech SA
- 31.14. CeQur Corporation
- 31.15. Aerami Therapeutics Inc.
32. Global Insulin Delivery Devices Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Insulin Delivery Devices Market
34. Recent Developments In The Insulin Delivery Devices Market
35. Insulin Delivery Devices Market High Potential Countries, Segments and Strategies
- 35.1 Insulin Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Insulin Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Insulin Delivery Devices Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
